scholarly article | Q13442814 |
P50 | author | John Anthony Hardy | Q6237755 |
Henrik Zetterberg | Q6252048 | ||
Martin R. Turner | Q39982364 | ||
Niklas Mattsson | Q57012884 | ||
P2093 | author name string | Jonathan M Schott | |
P2860 | cites work | Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography | Q21146623 |
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease | Q36632494 | ||
Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice | Q36890888 | ||
Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease | Q36934762 | ||
Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease | Q37010623 | ||
Handedness and language learning disability differentially distribute in progressive aphasia variants | Q37256206 | ||
Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum | Q37420383 | ||
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology | Q37699200 | ||
Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration | Q37899995 | ||
The amyloid state of proteins in human diseases | Q37994283 | ||
Logopenic aphasia in Alzheimer's disease: clinical variant or clinical feature? | Q38030310 | ||
Alzheimer's disease: mimics and chameleons. | Q38059197 | ||
Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level? | Q38123554 | ||
Tools and talk: an evolutionary perspective on the functional deficits associated with amyotrophic lateral sclerosis | Q38165909 | ||
The physical chemistry of the amyloid phenomenon: thermodynamics and kinetics of filamentous protein aggregation | Q38240692 | ||
Amyloid-beta dynamics correlate with neurological status in the injured human brain | Q42241419 | ||
Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups | Q45304952 | ||
Age-dependent modification of proteins: N-terminal racemization | Q45841436 | ||
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease | Q48408159 | ||
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings | Q48559548 | ||
Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease. | Q49125003 | ||
The selfish brain: competition for energy resources | Q56867013 | ||
Posterior cortical atrophy | Q57384523 | ||
Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases | Q58292492 | ||
Clearance systems in the brain-implications for Alzheimer disease | Q26801541 | ||
Neurodegenerative diseases: expanding the prion concept | Q27011744 | ||
Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments | Q27024117 | ||
Closing the tau loop: the missing tau mutation | Q27303641 | ||
The corticobasal syndrome-Alzheimer's disease conundrum | Q28250881 | ||
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases | Q28306079 | ||
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory | Q29614724 | ||
APP processing and synaptic function | Q29615873 | ||
The logopenic/phonological variant of primary progressive aphasia | Q30487374 | ||
Selective neuronal loss in ischemic stroke and cerebrovascular disease | Q30689231 | ||
Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease | Q33756751 | ||
Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease | Q33784013 | ||
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden | Q33803956 | ||
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. | Q33805339 | ||
Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. | Q33926731 | ||
The diagnosis of young-onset dementia. | Q34165340 | ||
Posterior cortical atrophy | Q34177264 | ||
TDP-43 is a key player in the clinical features associated with Alzheimer's disease | Q34232167 | ||
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions | Q34237637 | ||
The aging brain: morphomolecular senescence of cortical circuits | Q34349216 | ||
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
Synaptic retrogenesis and amyloid-beta in Alzheimer's disease | Q34926455 | ||
Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution | Q34999321 | ||
Neuronal activity regulates the regional vulnerability to amyloid-β deposition | Q35009626 | ||
Global gray matter changes in posterior cortical atrophy: a serial imaging study | Q35176229 | ||
Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy | Q35241767 | ||
Lifespan brain activity, β-amyloid, and Alzheimer's disease | Q35510426 | ||
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry | Q35543363 | ||
Defining and describing the pre-dementia stages of familial Alzheimer's disease | Q35557612 | ||
Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease | Q35661053 | ||
Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease | Q35735066 | ||
Prion-like spread of protein aggregates in neurodegeneration | Q35946138 | ||
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features | Q36217479 | ||
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies | Q36315342 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
neurodegeneration | Q1755122 | ||
P304 | page(s) | 1000-1004 | |
P577 | publication date | 2016-01-08 | |
P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
P1476 | title | Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease | |
P478 | volume | 87 |
Q50161290 | A method for inferring regional origins of neurodegeneration |
Q57134138 | Altered topology of the functional speech production network in non-fluent/agrammatic variant of PPA |
Q93093190 | Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation |
Q60530541 | Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis |
Q39251035 | Applying fluid biomarkers to Alzheimer's disease |
Q64948055 | C9orf72-mediated ALS and FTD: multiple pathways to disease. |
Q64980907 | Calcium-Binding Proteins as Determinants of Central Nervous System Neuronal Vulnerability to Disease. |
Q40518074 | Clinical heterogeneity in familial Alzheimer's disease |
Q46837391 | Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variants |
Q52582190 | Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis. |
Q46682283 | Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease |
Q54946040 | Molecular biomarkers of Alzheimer's disease: progress and prospects. |
Q91786497 | Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases |
Q47161310 | Propofol Induces Apoptosis of Neurons but Not Astrocytes, Oligodendrocytes, or Neural Stem Cells in the Neonatal Mouse Hippocampus |
Q33653691 | Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease |
Q37127867 | Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model |
Q47778608 | Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease |
Q37690530 | Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns |
Q91705233 | Selective vulnerability in neurodegenerative diseases |
Q51760891 | Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model. |
Search more.